$BIVI

$1.44 +$0.11 (8.27%) Live

$BIVI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 7.5M shares outstanding

Who owns BIVI?

By type of holder

Institutions 19.5% Insiders 2.3% Everyone else 78.2%

Concentration Top 10 holders own 102.8%

Terren S. Peizer 40.4% · Acuitas Group Holdings, LLC 40.4%

Institutional ownership

19.5%

+5.8 pts vs last qtr

Institutional holders

+2 vs last qtr

Net shares bought

+440.8K

by institutions in Q2 2026

New / sold out

5 / 3

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Morgan Stanley +530.3K
Renaissance Technologies LLC +60.0K

Biggest sellers in Q2 2026

Diametric Capital, LP −113.4K
Prelude Capital Management, LLC −59.5K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for BioVie Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2026

+1503.6%

+300.45% a year

Each share's claim on the business

−93.8%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $6.3M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years54% Under 1 year46%

Quarterly turnover

47.0%

of institutional shares changed hands

Top 10 managers, median time held

3 quarters

Super Investors

Investment managers reporting BIVI on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
MS Morgan Stanley	605.5K	8.03%	+530.3K (+704.9%)	2024	0.0%
Shares held by quarter Peak holding605.5K (Q2'26) Change over 8 quarters+602.7K Share of the company8.030% Morgan Stanley's full portfolio →
DC Diametric Capital, LP	256.6K	3.40%	−113.4K (−30.6%)	Q3 '25	0.1%
Shares held by quarter Peak holding370.0K (Q3'25) Change over 8 quarters+256.6K Share of the company3.400% Diametric Capital, LP's full portfolio →

Morgan Stanley

605.5K

% of company

8.03%

Change vs last qtr

+530.3K (+704.9%)

Held since

2024

Diametric Capital, LP

256.6K

% of company

3.40%

Change vs last qtr

−113.4K (−30.6%)

Held since

Q3 '25

26 more super investors behind a free account

See every manager holding BioVie Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting BIVI on Form N-PORT; together they hold 2.3% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$138K	70.9K	0.94%	0.00%	June 30, 2026
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$87.8K	38.5K	0.51%	0.00%	August 31, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$138K

% of company

0.94%

% of the fund

0.00%

As of

June 30, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$87.8K

% of company

0.51%

% of the fund

0.00%

As of

August 31, 2026

5 more funds behind a free account

See every fund holding BioVie Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
TS Terren S. Peizer 5%+ holder 13D · 15.8%	3.1M	40.44%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company40.440% Disclosed stake13D · 15.8% View the 13D/G filing →
AG Acuitas Group Holdings, LLC 5%+ holder 13D · 15.8%	3.0M	40.35%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company40.350% Disclosed stake13D · 15.8% View the 13D/G filing →

Terren S. Peizer

5%+ holder13D · 15.8%

3.1M

% of company

40.44%

Change vs last qtr

—

Held since

—

Acuitas Group Holdings, LLC

5%+ holder13D · 15.8%

3.0M

% of company

40.35%

Change vs last qtr

—

Held since

—

6 more holders behind a free account

See every insider and 5%+ holder of BioVie Inc.

Comments